Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CMND stock hub

Clearmind Medicine Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CMNDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CMND

In the news

Latest news · CMND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-119.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-87.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CMND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001892500
Company name	Clearmind Medicine Inc.
Country	Canada
Country code	US
Enterprise value	$-4.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA1850535016
Last refreshed	2026-05-10
Market cap	$5.6M
Market cap category	Nano-Cap
Price	$0.55
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CMND
Website	https://www.clearmindmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-118.3%
FCF yield	-98.95%
P/B ratio	0.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-6.6M
Net Income Growth Years	2%
ROA	-55.21
Roa5y	-95.42
ROCE	-95.05
ROE	-119.7
ROIC	-87.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.57%
Cagr3y	-90.79%
EPS Growth Quarters	14
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$11.1M
Cash	$10.3M
Current Assets	$11M
Current Liabilities	$2.9M
Debt	$7,977
Debt Equity	$0
Equity	$8.2M
Interest Coverage	-524.5
Liabilities	$2.9M
Long Term Assets	$122,753
Long Term Liabilities	$0
Net Cash	$10.3M
Net Cash By Market Cap	$184
Net Cash Growth	76.14%
Net Debt Equity	$-1.26
Tangible Book Value	$8.1M
Tangible Book Value Per Share	$5.43
WACC	-1.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.79
Net Working Capital	$-2.2M
Quick ratio	3.71
Working Capital	$8.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-305.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.57%
200-day SMA	16.76
3Y total return	-99.92%
50-day SMA	0.89
50-day SMA vs 200-day SMA	50under200
All Time High	26,280.1
All Time High Change	-100%
All Time High Date	2021-11-22
All Time Low	0.52
All Time Low Change	5.88%
All Time Low Date	2026-05-06
ATR	0.13
Beta	-1.12
Beta1y	2.05
Beta2y	1.1
Ch YTD	-69.57
High	0.57
High52	52.4
High52 Date	2025-09-19
High52ch	-98.95%
Low	0.54
Low52	0.52
Low52 Date	2026-05-06
Low52ch	5.88%
Ma50ch	-38.17%
Premarket Change Percent	-0.53
Premarket Price	$0.56
Premarket Volume	30,422
Price vs 200-day SMA	-96.71%
RSI	37.7
RSI Monthly	22.28
RSI Weekly	21.43
Sharpe ratio	-2.25x
Sortino ratio	-2.9
Total Return	-305.49%
Tr YTD	-69.57
Tr1m	-55.58%
Tr1w	-16.29%
Tr3m	-59.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,143,897%
Float Percent	99.54%
Net Borrowing	2,206,028
Shares Insiders	0.46%
Shares Institutions	0.27%
Shares Out	10,190,337
Shares Qo Q	749.61%
Shares Yo Y	305.49%
Short Float	4.57%
Short Ratio	0.37
Short Shares	4.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.4M
Average Volume	14,517,386.4x
Bv Per Share	5.49
Ch1m	-55.58
Ch1w	-16.29
Ch1y	-98.57
Ch3m	-59.2
Ch3y	-99.92
Ch6m	-97.99
Change	-2.08%
Change From Open	0.15
Close	0.56
Days Gap	-2.22
Depreciation Amortization	10,954
Dollar Volume	205,876.4
Earnings Date	2026-03-12
Earnings Time	amc
EBIT	$-7.8M
EBITDA	$-7.8M
EPS	$-17.04
F Score	2
FCF	$-5.6M
FCF EV Yield	117.51x
FCF Per Share	$-0.55
Financing CF	9,634,911
Fiscal Year End	October
Founded	2,017
Income Tax	$35,070
Investing CF	-611,479
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2026-01-31
Last Split Date	2025-12-15
Last Split Type	Reverse
Last10k Filing Date	2026-01-20
Ma150	8.75
Ma150ch	-93.7%
Ma20	0.77
Ma20ch	-28.84%
Net CF	3,476,570
Open	0.55
Optionable	No
Position In Range	33.79
Post Close	0.55
Postmarket Change Percent	-0.15
Postmarket Price	$0.55
Ppne	7,294
Pre Close	0.56
Price Date	2026-05-08
Ptbv Ratio	0.69
Relative Volume	0.03x
Share Based Comp	1,839,492
Tr6m	-97.99%
Volume	373,777

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CMND pay a dividend?

Capital-return profile for this ticker.

Performance

CMND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CMND?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Float: +99.5% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CMND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.7

Neutral momentum band

Price vs 200-day MA

-96.7%

50/200-day relationship not available

Beta (5Y)

-1.12

Less volatile than the market

Sharpe ratio

-2.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CMND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CMND stock rating?

Clearmind Medicine Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CMND analysis?

The full report lives at /stocks/CMND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CMND?

The latest report frames CMND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CMND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.